| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . 490 . 500 . 510 . 520 . 530 . 540 . 550 . 560 . 570 . 580 . 590 . 600 . 610 . 620 . 630 . 640 . 650 . 660 . 670 . 680 . 690 . 700 . 710 . 720 . 730 . 740 . 750 . 760 . 770 . 780 . 790 . 800 . 810 . 820 . 830 . 840 . 850 . 860 . 870 . 880 . 890 . 900 . 910 . 920 . 930 . 940 . 950 . 960 . 970 . 980 . 990 . 1000 . 1010 . 1020 . 1030 . 1040 . 1050 . 1060 . 1070 . 1080 . 1090 . 1100 . 1110 . 1120 . 1130 . 1140 . 1150 . 1160 . 1170 . 1180 . 1190 . 1200 . 1210 . 1220 . 1230 . 1240 . 1250 . 1260 . 1270 . 1280 . 1290 . 1300 . 1310 . 1320 . 1330 . 1340 . 1350 . 1360 . 1370 . 1380 . 1390 . 1400 . 1410 . 1420 . 1430 . 1440 . 1450 . 1460 . 1470 . 1480 |
# |
Score |
Template |
Links and tools | %id | First |
HTGPTPLSHAQNRQWALAQLEPDSPLYNIPFALKIRGALDFEILSHALELTAQRQDTLRSRFVSVDGKPFVETDPEMIFKIVPEEIGDRELEAALLDCARRPFDLAVAPLLRIHAFRTGPQDHVLLFLLHHIIGDALSAEILLNDVATFYASLSKKEAPPNGALPLQYSDFAIWQREQDTTNEVDYWRRTLAGAPPLLELPTDFVRPAIQGFSGESIRFSLNADLLARLRQLCDQQGATLFMGMLTAFSTLLQRVSGMRDIVIGTPVSERFHPDLENVIGMFANTLAIRLQTQGGENFNEALKAARDTALSAFANQTAPFEKVVDALSLPRTWSHNPLFQAMLVSTVETRRGAISLAGMEWDRLALPDTSSRVDLTLFIHETAEELSCRLEYRSDLFRRATMESLGEALVALLEKIVERPELPLDRQSLVSGNHQKRLRQWNETDAEFQPQRRCLHDFVTASAETSPQAIAVTDQDRSLSYAELDWRADRLASGLVAAGIGRGKRVGIRLERSVELVVAILAVLRTGAAYVPLDPRYPADRIEFIAADADLALILVTTENDISTIGQNFRCMTPGMVENLAGGAVPTPVTSGADLAYLIYTSGSTGRPKGVAIEHRNAVAFMQWCMHAFTKDQLSGVLASTSICFDLSIFEIFATLAAGGRIFMVDDLFAFPSAPFAGEVTLVNTVPTPMSELLKLGPLPQNVKTVCLAGEPLPRELVARIYANDQVECLYNLYGPSEDTTYSTVAPVPPSGEWFGIGVPIANTRAYVLDGEMNEVPVGVPGELFLSGSGLARGYWNRPGQTAERFLPNPFADCSQHRVMYQTGDIVRRRDDGGLDYMGRADRQLKLNGFRIEPGEIEAVLLQQEGVHEAVAGLWRDAANHPRLAMWIAGDPALEITKLVATLRQRLPEHFIPVLATRLDALPRLPNGKLDRSALPDPAAYGERATETASLLNDQEDVLAQIWQGLLGCGDIRRNDNFFSLGGDSILAIQLVSQARQKGLKMTPRDVFLHPTLASLAEVTHVESTVTVGTGHADDEATLGAIQHWLLDQDLPDLAHWNQGLILKLTRSLDPDRLEKAISRLLEEHQSLRARFLRKNGQWQQKFAPLSAMPPMQQLAATDENDVTDFARKLHAGFDLGAGPLFGAILATLPDGSGRLILAAHHLIVDGVSWRMIVADIERHYLEASTIRSGAVAAGSWNSRLSRSALFDGEEEYWRGVCEEDVRALPLDNESGSNTQSDAVTYRQTIDAETTRQLLRDVPECFSIASNEVLVAALYLTLRQWSGQPRLRLEMESHGRLNLFEDIDVSETVGWLTALYPVLFDTPDDATPDRLLLDVKDTLRRIPNNGVGFGVLKYLRNKAEHLDYGKPQLRFNYLGQMDAMFAIDSLFAPSGITSGPMYGAANPRDTILEINAMVVRGELQLQWVYGAQLHSEDTIRTLADHFRDNLETLIQHCLTGSGAGFSPSDFPLMDLGQDELDNLLKSF | Last |
1 | -309.000 | [Q] COG1020 Non-ribosomal peptide synthetase modules and related proteins |
ali |
100 | 1 | HTGPTPLSHAQNRQWALAQLEPDSPLYNIPFALKIRGALDFEILSHALELTAQRQDTLRSRFVSVDGKPFVETDPEMIFKIVPEEIGDRELEAALLDCARRPFDLAVAPLLRIHAFRTGPQDHVLLFLLHHIIGDALSAEILLNDVATFYASLSKKEAPPNGALPLQYSDFAIWQREQDTTNEVDYWRRTLAGAPPLLELPTDFVRPAIQGFSGESIRFSLNADLLARLRQLCDQQGATLFMGMLTAFSTLLQRVSGMRDIVIGTPVSERFHPDLENVIGMFANTLAIRLQTQGGENFNEALKAARDTALSAFANQTAPFEKVVDALSLPRTWSHNPLFQAMLVSTVETRRGAISLAGMEWDRLALPDTSSRVDLTLFIHETAEELSCRLEYRSDLFRRATMESLGEALVALLEKIVERPELPLDRQSLVSGNHQKRLRQWNETDAEFQPQRRCLHDFVTASAETSPQAIAVTDQDRSLSYAELDWRADRLASGLVAAGIGRGKRVGIRLERSVELVVAILAVLRTGAAYVPLDPRYPADRIEFIAADADLALILVTTENDISTIGQNFRCMTPGMVENLAGGAVPTPVTSGADLAYLIYTSGSTGRPKGVAIEHRNAVAFMQWCMHAFTKDQLSGVLASTSICFDLSIFEIFATLAAGGRIFMVDDLFAFPSAPFAGEVTLVNTVPTPMSELLKLGPLPQNVKTVCLAGEPLPRELVARIYANDQVECLYNLYGPSEDTTYSTVAPVPPSGEWFGIGVPIANTRAYVLDGEMNEVPVGVPGELFLSGSGLARGYWNRPGQTAERFLPNPFADCSQHRVMYQTGDIVRRRDDGGLDYMGRADRQLKLNGFRIEPGEIEAVLLQQEGVHEAVAGLWRDAANHPRLAMWIAGDPALEITKLVATLRQRLPEHFIPVLATRLDALPRLPNGKLDRSALPDPAAYGERATETASLLNDQEDVLAQIWQGLLGCGDIRRNDNFFSLGGDSILAIQLVSQARQKGLKMTPRDVFLHPTLASLAEVTHVESTVTVGTGHADDEATLGAIQHWLLDQDLPDLAHWNQGLILKLTRSLDPDRLEKAISRLLEEHQSLRARFLRKNGQWQQKFAPLSAMPPMQQLAATDENDVTDFARKLHAGFDLGAGPLFGAILATLPDGSGRLILAAHHLIVDGVSWRMIVADIERHYLEASTIRSGAVAAGSWNSRLSRSALFDGEEEYWRGVCEEDVRALPLDNESGSNTQSDAVTYRQTIDAETTRQLLRDVPECFSIASNEVLVAALYLTLRQWSGQPRLRLEMESHGRLNLFEDIDVSETVGWLTALYPVLFDTPDDATPDRLLLDVKDTLRRIPNNGVGFGVLKYLRNKAEHLDYGKPQLRFNYLGQMDAMFAIDSLFAPSGITSGPMYGAANPRDTILEINAMVVRGELQLQWVYGAQLHSEDTIRTLADHFRDNLETLIQHCLTGSGAGFSPSDFPLMDLGQDELDNLLKSF |
1483 |
2 | -111.000 | [Q] KOG1178 Non-ribosomal peptide synthetase/alpha-aminoadipate reductase and related enzymes |
ali follow.. |
12 | 1 | ............................................................................................................................................................................................................................................................................................................................................................................................................................................MLCDSSES----VSFSSISKEED--TPIARLLKNAKETPDHRFISVYNEKYTYTELLRRVNTIAKFCDDLGLGK--TVGIHMGHELDFLCSIFALWATGRTCVIFNQIWSQQVVRVLVKRLNISDLLYHEYKPKFEV--DTLNATSLASLPLDIDAPCIRAGLEPEVALINHSSGSTGVPKSMPFLMKKYALGYDYGTPEFMNHLSTPMVM--ATSFALTTLSWINALYCNGNLLYPSSSAWNVYYALRAGCERLIILPNLLVLTLQKEECFPACKLVAAGGEMVPANMYHTCKRVLPNATIYPQYGTTESGLVSFLAYNGKDTLVYFPGKTVKKLMLVTEDNEAVPEKIGCEGFVCVVTDVQSEPYVGDDAETIQSRNSTFINYDGQ--PAVRFADLAVWKGKLGITIKGRLGRRVKRNGVFFDLKYFDQVVVGLKEVKDAFSFFI----FNRFVLVYVPAYNGVDPVTLKQKLNKELRDHHLFSSCFPLADIPRNAAGKVDLKSIETYASKSVEDQRLPVLLNPVAIEISKIASKILQNPSEGKDAPLYSCGLDSIHSVRFFHAIQSHHLEGPIRYNMNSNCTPNSIASIIQKKSYNVSSITYE-SILPTNGQYFLLTGATGYFGRRFLEYLVKLNISVSDEAAKERLISLVPSLRISSENIIVWAAHVEEIRFGLDDAKWEFLVENVSRIYHMAAEVHWMKSYQELRPANVLGTVLELSVMGPKAL---YFISGGGQQEVELDDDTQSAYAL-----------SKYVAELLCRKISDLG-------HPLIYVIRPGFIIANDGEILSRDFFWRFVATALRMGIWPQSDESQSLVFHISTTDALCMTLTQILEKEADAYAPLLAYDKFDGDEF-CESMKNVKLDFVT----------LEDWLKALEKDVDEKGEDHPLFALQHATKF.............................................................................................................................. |
943 |
3 | -62.200 | [Q] COG1021 Peptide arylation enzymes |
ali follow.. |
21 | 23 | ..................................................................................................................................................................................................................................................................................................................................................................................................................................................................QDVPLTDILTRHAD--SDKTAVIEGERAFSYRQLNQAADNLACSLRRQGIKPGETALVQLGNVPELYITFFALLKLGVAPVLALFSHQRTELNAYAMQIAPTLVIADRQHTLFAGEDFLNTFVADAAMRQAAEDFTATPSPADEVAYFQLSGGTTGTPKLIPRTHNDYYYSVRRSNEICGFNEDTRFLCAIPAAHNYAMS-ALGVFLAKGTVVLATSATLCFPLIEKHQINATALVPPAVSLWLQAIQELASLRLLQVGGARLSATLAARIPAEIG-CQLQQVFGMAEGLVNYTRLDDSPERIINTQGRPMPDDEVWVADADGNPLPPGEIGRLMTRGPYTFRGYFNSPLHNASAFDANGF---------YCSGDLISIDQDGYITVHGREKDQINRGGEKIAAEEIENLLLRHPVVIHAALVSMEDELLGEKSCAYLVVKEPLRAVQVRRFLREQVAEFKLPDRVECVASLPLTPVGKVDKKQLRQ.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
528 |
4 | -56.300 | [IQ] COG0318 Acyl-CoA synthetases (AMP-forming)/AMP-acid ligases II |
ali follow.. |
17 | 1 | ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................ETLYESLLAAQYRYGAGKNCIEDFTPDTYRKLLTKTLFVGRILEKYSV-EGEKIGLMLPNAAISAAVIFGAVSRRRIPAMMNYTAGVKGLTSAITAAEIKTIFTSRQFLDKGKLWHLPEQLTQIFAHLLAPRLAQVKQQPEDAAIILFTSGSEGHPKGVVHSHKSILANVEQIKTIADFTANDRFMSALPLFHSFGLTGLFTPLLTGAEVFLYPHYRIVPELVYDRNCTVLFGTSTFLGNYARFANPFYRLRYVVAGAEKLQESTKQLWQDKFG-LRILEGYGVTECAPVVSINV-PMAAKPGTVGRILPGMDARLLAVP----GIENGGRLQLKGPNIMNGYLRVEKPGVLEVPSAENSRGETERGWYDTGDIVRFDENGFVQIQGRAKRFAKIAGEMVSLEMVEQLALGVSADKMHATAIKSDASKGEALVLFTTDSE-LTREKLQHYAREHIPELAVPRDIRYLKQLPLLGSGKPDFVTLKSWVDAPEQHHE........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
516 |
5 | -54.300 | [I] KOG1179 Very long-chain acyl-CoA synthetase/fatty acid transporter |
ali follow.. |
15 | 58 | ....................................................................................................................................................................................................................................................................................................................................................................................................................................................VLLKVKAKVRQCLQERRTVPILFASTVRRHPDKTALIFTDTHWTFRQLDEYSSSVANFLQARGLASGDVAAIFMENRNEFVGLWLGMAKLGVEAALINTNLRRDALLHCLTTSRARALVFGSEMASAICEVHASP-LDPLLKDAPKHLPSCPDKGFTDKLFYIYTSGTTGLPKAAIVVHSRYYRMAALVYYGFRMRPNDIVYDCLPLYHSAGIVGIGQCLLHGMTVVIRKSASRFWDDCIKYNCTIVQYIGELCRYLLNQPPREHQVRMALGNA--SGSPSGPTFPAASTYPRWLSSTGPECNCSLGNFDSQVGACGFNSLVRVNEDTMELIRGPDGVPCQPGEPGQLVGRIIRRFDGYLNQGANNKK-IAKDVFKKGDQ---AYLTGDVLVMDELGYLYFRDRTGDTFRWKGENVSTTEVEGTLSRLLDMADVAVYGVEVPGTEGRAGMAAVPTGNCDLERFAQVLEKELPLYARPIFLRLLPELHKTGTYKFQKTELRKEAFDPAIVKTIYIEKGRYVPLDQEAYSRIQA................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
636 |
6 | -49.400 | [I] KOG1176 Acyl-CoA synthetase |
ali follow.. |
22 | 34 | .................................................................................................................................................................................................................................................................................................................................................................................................................................................................PSKESLDITTFISSQTYRGKTAFIDADHRISFSDLWMAVDRVADCLLHDGIRRGDVVLVLSPNTISIPIVCLSVMSLGAVLTTANPLNTASEILRQIADSNPKLAFTTPELAPKIASSGISIVLEEMMKKEPSGQAVRNQVHKDDTAMLLYSSGTTGRSKGVNSSHGNLIAHVARYIAEPFEQPQQTFICTVPLFHTFGLL-VLATLALGTTVVILPDLGEMMAAVEKYRATTLILVPPVLVTMINKADQVSFLRTVRCGGAPLSKEVTQGFMKKYPTVDVYQGYALTESNGAGASIESVEESRRYAVGLLSCGVEARIVDNTGQVMGLNQTGELWLKGPSIAKGYFRNEEEIITS------------EGWLKTGDLCYIDNDGFLFIVDRLKELIKYKGYQVPPAELEALLLNHPDILDAAVI.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
478 |
7 | -49.000 | [I] COG0365 Acyl-coenzyme A synthetases/AMP-(fatty) acid ligases |
ali follow.. |
19 | 18 | ........................................................................................................................................................................................................................................................................................................................................................................................................PTEFSERAYVRSGRE-YEQLYSRAASNPEGELAEQELHWFKKWDQVLDWQPPFAKWFVGGQLSHNCLDRHLTTRRNKAAIIWEGEIITYAQLHREVCQFANALKSLGVQKGDRVAIYLPMIPEAAITMLACSRIGAPHSVVFGGFSAEALRDRLVDAEAKLVITDKALEHGAPSVENVIVVQHELQPQQSAHCPAEPIDSEDMLFILYTSGSTGKPKGVVHTTGGNLYTHMTTKWIFDLKDTDVYWCTADVGWITGHSYVYGPLSNGATTVMYENPGCFWDVIERYGVNIFYTAPTAIRAFIRMGEALSSLRLLGTVGEPINPEAWMWYHRVIGKCPIVDTWWQTETGIMLTPLPGAIPTKPGSCTKPFPGIVAEIVDLDGNPVESDQGGFLVIK-PSMIRDVYGDTDRFRHTYWEH---QPKEGQYLYFAGDGARRDKDGYFWVMGRVDDVINVSGHRLGTMEIESALVSHPLVAEAAVVGRPDELTGEAIFAFVSLEGNAEPSDLVKHVTEEIGAIARPAEIRFTDVLPKTRSGKIMRRLLRSLASGQEISGDTSTLEDR................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
644 |
8 | -47.700 | [I] KOG1175 Acyl-CoA synthetase |
ali follow.. |
19 | 117 | ......................................................................................................................................................................................................................................................................................................................................................................................................................................................................CYNCLDKNVEALGDKTAIHWEGNSLTYSELLQRVCQLANYLKDNGVKKGDAVVIYLPMLMELPIAMLACARIGAVHSVVFAGFSADSLAQRIVDCKPNVILTCNTTRENTKWQNGRDVWWQDVISQYPTSCEVEWVDAEDPLFLLYTSGSTGKPKGVLHTTGGMIYTATTFKYAFDYKSTDVYWCTADCGWITGHSYTYGPMLNGATVVVYPDPGRCWDIVDKYKVSIFYTAPTLVRSLMRDDDKRKSLRVLGSVGEPINPSAWRWFFNVVGDSRISDTWWQTETGFMITPLPGAWPQKPGSATFPFFGVQPVIVDEKGNEIEGECSGYLCVKGSGAFRTLFGDHERYETTYFKP--------AGYYFSGDGCSRDKDGYYWLTGRVDDVINVSGHRIGTAEVESALVLHPQCAEAAVVGIEHEVKGQGIYAFVTLLEGVPYSSLVLMVRNQIGAFAAPDRIHWAPGLPKTRSGKIMRRILRK--IASRQLEELGDTSTLADPSVVDQLIALADV.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
693 |
9 | -44.700 | [I] COG1022 Long-chain acyl-CoA synthetases (AMP-forming) |
ali follow.. |
16 | 13 | ................................................................................................................................................................................................................................................................................................................................................................................................................................................................PCALPPPNEMLLRWAKERPNEVYLKQIIVEFTYAEVADKALRLVSALRALGADPGDKVALISKNCAEWFICDLAMMLGDYISVPIFPTAGSETIDYCLEHSESKILIVGKLDDNKAPSAAKCQYEFQTLIKQHQPSEERPTHFDEKLMSIVYTSGTSGQPKGAMLTYGAFTWSAQQLINHIGIEENDRLFSYLPLAHITEVYIFGSSIIGGVLTAFPESLDTFIEDVKMHRPTLFISVPRLWTLFLADGLGLDQARVLGCGSAPVSPALLEWYRSV--GLNITEAWGMTESFAYSTLNYPFRADKIGTVGNAGPGIELKIAED----------EEILVRSKGLFAGYYKNDTATAESFNDDGW---------LHTGDIGSLDSEGYLTIQGRKKDTFKTKGKFVAPVPIEKKLFEYSRVEMMCLI----GSGLPAPILLAVPHNFFDRARYERTTQEQIKGVLMIKDPWSIDNGILTPTLKIKRHVL---------EKKYHDVGQNWPKGQLVVWEE...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
563 |
10 | -41.100 | [I] KOG1180 Acyl-CoA synthetase |
ali follow.. |
19 | 78 | .........................................................................................................................................................................................................................................................................................................................................................................................................................................................DGLMNSSFEGIHDLGTQWEECVRRYGNQPCMGTREHWRSYAQVDKRVNMIASGLTSLGQQEKEPIILFAETREEWMTTALACMKMNFPIATMYATLGDEAVQFAINEVGAKTIFTSEALISKVKKDQLLSRGEREYCMLLGAYPVPTRSKKDDLAFIMYTSGTTGNPKGVMISHQNIVAVTAGQAFNIVLGPDDRYIGYLPLAHILEVCAEMVVFTKGVRIGYSSAQTGEHGDCWVLQPTLMACVPAVMDRIFKGKLLGGKVRQILSGGAPLSPE-TQRFMNICFCCPVVQGYGLTETCGGGTIAD-IHDLSTGTVGPPLTCCEILLQEAGYSPKNDPPQGEILISGPNVALGYFKNDEKTKEEFVK-------NGKTFFATGDIGEFREDGSLKIIDRKKDLLKLHGEYISLGKVETNLLTNPNVDNVCVY---GDSNKSFLVALVVPNQKN-QKELAQYGASKLQRVEIPQKIFICHE--LTEALKLKRKNI----------------EKAFRKELDELYK....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
726 |
11 | -40.200 | [I] KOG1256 Long-chain acyl-CoA synthetases (AMP-forming) |
ali follow.. |
17 | 60 | ..............................................................................................................................................................................................................................................................................................................................................................................................................................................DGGRKAAWLGDGPLQHGWFEGVLTTYSGIR-RGPTVGGKEMLGKRVEWISYDQAFETSDHASQAIRKLGIEIGEKIGIYSNNRPEWILSEMAIHNFSNVSVPLYDTITNDDMHYITNLCEISLMFVDAEIKTKQLIRDKSIVQFNECSDDIKEHRPHVPPTPETLATISFTSGTTGRPKGVMLTHLNMCSATMSCEEFENAGVQDAYLSYLPLAHIYERLCLLSNFMIGSRIFSRGDPKLLVDDVQALAPRSFATVPRVIDKIHKQMLLGPNIRQLILGAAKSDVS-AMRFARGAFGVEVLEGYGQTETSGPTTL-QLVGDTRIGCVGPPMACAMIKLIDPELGYSVDKNGGEVLVKGHNVTSGYYKNPEATASSFTEDGY---------MKTGDIGRFTAEGSLQIIDRRKNVFKMQGKFVAPDLTESLYTSSSFVQQIYVH---GDMEKPWLVAIVVPDPECNIPILADDVLRQFVELTEEDKRPRYEGVYTTPTLKNKRNAI----------------AQFFKAEIDGMYKKI..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
690 |
12 | -37.400 | [R] COG4908 Uncharacterized protein containing a NRPS condensation (elongation) domain |
ali follow.. |
13 | 3 | KITSYPAEPSDIKHYISG--EKMKNDHHLHTVLTFDNHLNIDVLKKAVMQSTKKLRLLLCHFKETNKGAFWQESVFSAEDLVFLI-KTTEPEAEVNRALVRKLSTENGPQIRLTVVR-TESADKLVIILNHMLADGAGFKEYLYLLSELYSKLLENPNYQANL-SLGSRNLKQVFDQFSRKEIKTIFTEKTNRKTVPFPLKGDPKNPKI-------IWTKLPKEVFDGIVHYAKENDATVNDVFFAAMVRIVQQTTHQNELSIDCPVDLRKYLPGKASQGITNLTANITCQINANTSFESTLQAVKNS-LNPQKNSLTPLRIYYLLELIFKKKSYSFA-KTSFTNIGIIDEEKLIFEGSTLTDCFICGSLKY-FFQVAATTFRGELTLSTNLHGTTRDHDWQKHFLDQLAREFTLLVQDE....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
426 |
13 | -25.400 | [Q] COG3433 Aryl carrier domain |
ali follow.. |
15 | 1 | ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................AALRALILPLLDEDEPLDDENLIDYGLDSVRMMGLAARWRKVHGDIDFVMLAKNPTIDAWWALLSRGVE.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
70 |
14 | -17.600 | [H] COG1541 Coenzyme F390 synthetase |
ali follow.. |
16 | 17 | .......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EIQERKLKALVSTVYQYSPFYRQRFREKSLNDLPKLPFTKKQDLRDTYPFGMFCVPLSQVVRFHASSGTTGKPTVVGYTANDIRNWVESLCRALGVSSDDIMQIAYGYGLFTGGLGFHYAAERLGATVLAGNTARQIELMKDLGSTVMACTPSYMIYLAEYASQMGNLRAGIFGAEPWSEETRKRIEDKT-GITAYDVYGTSELSGPLFTECTERQ------GLHIWADMFLIIDPKTEQVGEGEKGELVV---------------TTLTKEALPLIR-------WRTGDITYMETDGR-RILGRADDMLIIRGVNVFPSQIEHVLMQIPEVGEHMIIVDRREDGLDELTVQVELSDKAEIDTLEKKIADKLKSVLAKVEVVNPGTLQRF-EGKIDRRKI.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
433 |
15 | -11.900 | [E] COG2902 NAD-specific glutamate dehydrogenase |
ali follow.. |
10 | 95 | .......................................NMPFLYDSVMGEVTSSYRGLYLAVH----PILVRDDEAQGYRLAEPEDDPAENISL-------IQLHIAPLTPQAASALEERLRFVLTQVQSAYRD---WRPMLTKLDEALDELSKRGSSRRKTERTEAVEFLNWLRNDNFT--LGMRDYTYSGKGKNAKIERGDGVGLGSLSDPDVRVLRLGKNAVTTTPEILALDGPDFLIVTKANVKSIVHRRAYMDYIGIKRFDEDGNVIGELRIVGLFTATAYTRSVKQIPLLRAKVADVERHFGFDPNSHSGRILQNTLEAY---------PRDDLFQIETDLLIRFIEQIMELS--------DRPRVRVLARIDRFDRFVSAIIFVPREEYNSYVREKIGDYLSRVYDGHISAYYPAFPEGAVARVHFIVGRTEGKTPRIAQDKLEDAVSDIAARWIDHFVALSEPGAPVLDVDYQEAFTPEEAIGDMPDILAAANGEPVRIEFYQQEGPLSRRVPLLENLGFNVDIGVVSEGEKRDIVLHDMELSVAAGTTLDLPHYGPKLEEAFLA------------SGKVDNDNFNRLILACGLNVREVSVL---RAYARYLRQTGIVYSQEHISETLYKYP---------------------ISRNIFALFKAGFDPSIEEKKRVKKLAEIHKAIEAALSGVPNL-------EDRTLRRYVNAIDATLRTNYFQKNADGTPRDLLAFKFDPKHLDLPDPRPFREIFVYGTEVE-------G-VHLRFGKVARGWSDRGQDYRTEVLGLVKAQQVKNAVIVPVGAKGGFFPKNLPAGGSR--DEVFNAGREAYKTYIRTLLSITDNIVDDAIVPPADTLRLDGDDPYFVVAADKGTATFSDTANGLAHEA-----FWLDDAFASGGSAGYDHKKM-----GITARGAWETVKRHFREMDTDIQTTPFTVAGVGDMSG--DVFGNGM----LLSEKIRLIAAFDHRDIFIDPDPDTDKSFAERKRLFELPRSSWQDYDRSTLSAGAMIISRSEKSVTLTPEAVAAIGLDKSVATPFEIMTAILKAPTDLL-TYIKAAVETNAEVGDRAN-------DPIRVNATELRAKVIGEGANLGITQKGRIAYVNSSDVEVNIKIALASAVNSGRLTMPKRNQLLASMTPDVAQLVLRNNYQQSLAISLTERLGLANREELGRLMGALEATGQLNRKVETLPNNAEFSERYASGKPLTRPEIGVLLSYAKLTLFDALVAS-AKMQKNYANDREIVGGPGFVQKLADASGLLAADVVKAAVIVEDG-------------LKRLWTEVDALDGKVGGQVQNGLYATITRIFSDASRLYLQTGSAGAAAGDMATEIERLKTAIKTLSPAATKYRRELGVTEIDGVPSGLLEELDTLSLLVYVPEIMRIAESAGTTLARAAE................................ |
1478 |
16 | -10.300 | [R] COG1204 Superfamily II helicase |
ali follow.. |
9 | 520 | ......LNRIQSHLY--------PIAFGTDENILLTGAGKTNVAMLCILNELQKHLREDLSFNLQNFKIVYIAPLKALVQEMVNNFSKRTPYNIRVAELTGDSQLTKQQISETQIIVTTPEKWLVIIDEVHLLHDGPVLESIVARIFRHQEETLEQRLVGLSATLPNYTDVASFLHVDPKKGLFYF--------STYRPCPLKQEFIGITEKTPFKRMQTTNEACYEKVMQHAGKNQVLIFVTAKTARFIRDKALEEETI--FAIHHAGMRREDRQTSEDLFIQVLVSTATLAWGVNLPAIIKGTQVYSPEKGIWTELSPQDVLQMLGRAGRPQFDTYGEGIIITAHSELQLSLMNQQLPIESQFMRRLADCLNAEVSLGTVRSILYVRMLRSPALYSVGPEYDDDKYLVQKRADLLHSAAILLEKCKLLVYNRQSGTLELGKVAASYYVTHNSMAIYNRLLMQTTSFIELFRVFSFSDEFKHIPVREEELQSYISRQRLDGFALVAYVTQSAGRIMRAIFEISLRRGWSSVA-PNCPSEVIRFDLDPAELGELVGVPKEGRRVYNMVQSFPRLSVEAHVQPITRSLVRVELVINSQFNWDDHLSGTSEAFWILVEDVDGDRLLHYEQFFLLKKYKDDEHINFTVPLLEPLPPCYFIKIVSDRWLHSITKVPLSFQRLIMPEKFPAPTPLQNAPVSSLNNPSFISLYPN-NKIQTQVFNSVYKTNDSVFIGAPNGSGKTVCAALLHHWSQEDYGTAV-QEIVDRRYEEWYGKFSDLGDGKTGERSQDLKLIQVADL----CTPSQW--DSLSKRWRSMRSIQK-DELQLLGGGPLIVISRIRYMAVQLEKNIRVVGLSVSVANARDLGEWLGTSPQCI--TIHLQSFSITHFPSLMLAMSKPIYRSLKNFISQRVFTPDRKVAKQLAFDLVTFSMADEDEYLFSLMENEAFNKVEDAALQQSLKHGIAYISEITSQYLYRHGLIKVL---IASRDVIYSLKAKSNAVIVMGTISELLQMLGFTASIGSSE-LSQVILMTVTTKKEYYKKFLNEPLPMESHLQVWLHDAFVSEISTQTIESKQDAVDWLTWSY---------MYRRLVANPAYYGLQDITHESVSEFLSDLVET---TMNDLSEARLITVDDEDDSCIASHYGITYITMQTFALSLSERTKMKGLLEIVTSAAEYEQLPIRKYEDIVLER------------------------------------IHSRLPVRLSNPNYEDPHTKSFILLAAHFSRFELPPGLVIDQKFILTRVHN-----------LLGACVDTLSSEGHLIACIRPMEMSQMVTQAL................................................................................................................................................ |
1989 |
17 | -10.100 | [TDBLU] COG5032 Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family |
ali follow.. |
9 | 575 | .........................................SLREFIMKALASTSRCLRVVAAKV---PIFIKGPNNLDIVEFHKESKALIFNTLKILAVENTAILETVILSWISLSRVVEEEELHFVLLEVISSVINSGIFYQGIGSALQQIASTRHISVWQLLSPYWPTVS----VAIVQGMGKKPNIASLFAQLMNISEGD----LIRTQAYTLPFLVLTKNKALIVRIAELSQSDVATLCLTNMHKILASLLTTDH-LLSLATSDFEKVDLTSLL-ITVELLQLYQNDVPHEKIENALRKVAMIVSQVVNDEDLSNKELLYDFFNNHILGILAEFSNILNDLKGKTSINEKIKTISLCGGAVKLGLPQILSNLQSAFQNEHLFYAIKAWFSLILATKEPEYSSIAGLSLVILPQEAELVIQIFDFISSDTHKCLQGLKWAIPTSLACFSLKAKEIFCSLQNEDFYSELQSIIKCLTNENEPVCYLGLQKLELFFQAKVDELHDTLNLDISNEVLDQLCLLDC-GELGAIDPS----RAKAQHIIKETVVL--------------------DNFENGEESLKFILDFMQSQLIPAFLVTTDTKAQGFLAYALQEFLKLGGFKSAVINKKKGLTVVTEHWMSLPDLSKRVLIPFLTSKYHLTPIPKIDIRYPIYKENVTIHTWMQLFSLKLMEYAHSQNAEKIFGICSKVVKDQEVNIPCFLLPFLVLNVILTESELLVINQPGPDGLNSVGQQRYTSFVDVFFKIVDKRNWDRRSAIARKENRYMSVEDATSRESSISKVESFLSR-FPSKTLGIVSLNCGFHARALFYWEQHIRNATAPYAALESDYRVLQEIYAGIDDPDEI-EAVSLNFHDYSFDQQLLLHENSGTWDSALSCYEIIIQKDPE--KKAKIGLLNSM----------LQSGHYESLVLSLDSFIINDNHEYSKMLNLIDSLKKCLSKSNLESFEAKLGSIFYQ------------------YLRKDSFAELTERLQPLYVDAAT--------AIANTGAHSAYDCYDILSKLHAINDFSRIAETDGIVSDNLDIVLRRRLSQVAPYGKFK--HQILSTHLVGYEKFENTKKTAEIYLEIARISRKNGQFQRAFNAILKAMWWWHQGQHRKAISELNFSLNNNMFDLVDEHEERPKNRKETLGNPLKGKLTKWLGKAGQLGLKDLETYYCENYLGHHRVLMYEEEQKLPVNEQSERFLSGELVTRIINEFGRSLYYGTNHIYESMLLTLWGAEELRLSKDDGEKYFREHIISSRKKSLELMNSNVCRLSMKIPQYF----------FLVALSQMISRVCHPN-----------------NKVYKILEHIIANVVASYPGETLWQLMATIKSTSQKRSLRGKSILNVLH-----------SRKLSMSSKVDIKALSQSAILITEKLINLCNTRINSKSV..................... |
1999 |
18 | -9.510 | [O] COG4934 Predicted protease |
ali follow.. |
8 | 64 | .................................................................................................................................................................................................................................................................................................................................................................................................................................VNGSMEMNVIIGIIPNNLNEL-------------ENYATEI------SMPGSPLY---RHWLTTQQINSMVETVSSYFSKLGFSVQVK--VAISGNASMMESVFHT-KNGQVLF--SIELPGSVARYVLSVDGLSNFQMTTNPVYPTLSDYTSSGLIKNFENVTGYTPPFQALFPSDLP--IYTPGANGTGTTIAIVMGTGYINATLAYPAWNYNDMLKYGKEVEFTLDT---QYSATVAPDAHLDIMAIPSL--------------------------------------STVALDNAYITLYELPNTPQVITNSWSGSEDSWWNMYGPYWQSADLM--------NLLFE--------------LLSMKGSTI----------------------------VAATGD------SGSGEFPGTSPWVTGVGGDQVTMFN--ANYSSLPPYYWSNLRLNIVNIGLKHNNGFTQTYWDNNQYVVVNGAPEVISTGAGSAALSIFFKQPWWQHGYTGRMSEVEVSAEAGFNQTEL----------------------VDGMWGSWFFGGTSEATAGMIADVISYNATIHVNYLDINPLLYEIGNEYMQNPGKMPDPALMVNDSYTLDGPQNYPSNYYTTDNGYSMLTGW---GTINVGNFKIDLEQFLTQ............................................................................................................................................................................................................................................................................................................................................................................................................... |
740 |